glp 1 biolab Berobenaride is a GLP1 agonist with half life of 15 days with the potential to be the first monthly injection for obesity. Fully biased toward cAMP Body-wide multi-omic counteraction of aging

PMID: 5 ZhaoLSunLYangKZhangZLiZWangMet al

This treatment can also increase sensation in the area resulting in improved performance during intercourse

Another important factor was it had the capacity to bind to albumin, a large protein common in the bloodstream, which would make the GLP-1 molecule too large to be quickly cleared by the kidney

A New Perspective on the Antimicrobial Mechanism of Berberine Hydrochloride Against Staphylococcus aureus Revealed by Untargeted Metabolomic Studies

Limited randomized controlled trials suggest these therapies may be beneficial and have similar response rates

doi: 10.1002/art.1780400215 506 Ortega-HernandezODCucciaMBozziniSBassiNMoscavitchSDiaz-GalloLMet al